Cerezen is the first and only device certified under the new EU framework. The US FDA is a bit slower to approve it.

Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

Earlier this year, two new drugs that have been shown in global trials to slow early-stage Alzheimer's disease, donanemab and lecanemab, were rejected by the Scottish Medicines Consortium (SMC), ...

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...

However, lecanemab doesn’t stop the relentless march of Alzheimer’s disease, it just slows it down. The medication, sold under the brand name Leqembi, also comes with a hefty price tag and a risk of ...

Farmington Hills, Michigan, Oct. 23, 2025 (GLOBE NEWSWIRE) -- “We made every effort to bring this treatment to U.S. patients first,” said Cerezen Founder and CEO Manoj Bhargava. “However, it seems ...

A new vitamin K-based treatment could help replenish lost neurons in Alzheimer's patients, offering hope for slowing ...

After decades of unsuccessful research, two new drugs and a pioneering blood test have recently given Alzheimer's patients hope of fighting back against the debilitating disease - but questions remain ...

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...

Esther Landhuis is a journalist in the San Francisco Bay Area. She holds a Ph.D. in immunology and covers biomedicine in all dimensions, from bench discoveries to biotech to health care. Alzheimer’s ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other ...

The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether memory problems ...